Aarti Drugs Ltd

BSE: 524348

total announcements

524348.BO · 15 min delayed

BSEResultResults31 Jul 2026

Aarti Drugs Ltd

Financial Results for the quarter ended June 30, 2026

Aarti Drugs Ltd has announced its financial results for the quarter ended June 30, 2026, with a standalone profit before exceptional items and tax of Rs. 6,994, and a total tax expense of Rs. 1,700. The company has reviewed and approved the results by its Audit Committee and Board of Directors.

Q1 Earning Conference Call

Aarti Drugs Ltd has scheduled a quarterly earnings conference call for August 3, 2026, to discuss its financial performance for the quarter ended June 30, 2026.

Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Financial results for the quarter ....

Aarti Drugs Ltd has scheduled a board meeting on July 31, 2026, to consider and approve financial results for the quarter ended June 30, 2026.